Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate vs Placebo and Propranolol for Migraine Prophylaxis
NCT00236561Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Apr 2001
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of topiramate in migraine (4 arms), sponsored by Johnson & Johnson. Primary endpoint: Change in the monthly (28 days) migraine period rate from the Prospective Baseline Period to the Core Double-Blind Phase at 26 weeks. Started Apr 2001; status: completed.
02
Drugs
topiramate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00236561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236561.